Hormone deprivation therapy for prostate cancer may raise diabetes risk
Men with prostate cancer are at higher risk of developing diabetes or diabetes risk factors if they receive androgen deprivation therapy (ADT) to block the production or action of male hormones that can fuel the growth of this cancer. The results of this new study on the second-most common cancer in men are being presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston. "These patients may benefit from counseling, screening and closer monitoring for the development of these complications," said the study's lead author, Maria Luisa Cecilia Rivera-Arkoncel, MD, a fellow at the Philippine General Hospital in Manila.
This study adds to the scientific evidence that ADT may increase the chance of diabetes. Sometimes called medical or surgical castration, ADT is a common treatment when prostate cancer has spread outside the prostate. It can be permanent by surgically removing both testicles (bilateral orchiectomy), or, more often, temporary by using medications, such as gonadotropin-releasing hormone (GnRH) agonists, to prevent the testes from making testosterone.
In their study, Rivera-Arkoncel and her colleagues compared 38 men with prostate cancer who received ADT and 36 men with less advanced prostate cancer who did not receive hormonal therapy. Men in the ADT group either underwent bilateral orchiectomy at least six months earlier or received six or more months of treatment with injections of GnRH agonists. Both groups received treatment at the Philippine General Hospital from 2004 to 2010. Although the average age of the two groups was not the same at the beginning of the study, the groups were similar in terms of other diabetes risk factors, Rivera-Arkoncel said.
Based on a review of medical records, the researchers identified patients with Type 2 diabetes or the metabolic syndrome. This syndrome is a cluster of metabolic risk factors that increase the chance of developing diabetes, heart disease and stroke. The criteria used for diagnosis include a large waistline plus two of the following: low HDL ("good") cholesterol, high triglycerides (fats in the blood), high blood pressure and high blood sugar.
Men in the ADT group had a twofold increased probability of having diabetes after ADT, compared with the non-ADT group, Rivera-Arkoncel reported. According to the data, the prevalence of diabetes was 42 percent in the ADT group and 19 percent in the other group. In addition, the group receiving ADT had a higher prevalence of the metabolic syndrome than the non-ADT group did: 37 percent versus 28 percent, respectively.
"An increased risk of diabetes with ADT has not previously been demonstrated in the Filipino population, which already has a high prevalence of diabetes," she said.
She cautioned, however, that their cross sectional analytical study suggests, but cannot prove, that ADT is the cause of the increased prevalence of diabetes in men who received this hormonal therapy.
Source: The Endocrine Society
Articles on the same topic
- Breast cancer drug pushes colon cancer cells to their deathWed, 8 Jun 2011, 19:39:17 UTC
- Mayo Clinic, NCCTG find no tie between PTEN and response to breast cancer drugSun, 5 Jun 2011, 1:02:42 UTC
- Obesity raises breast cancer survivors' risk of dying of the cancerSat, 4 Jun 2011, 19:03:30 UTC
- Fetal programming of disease risk to next generation depends on parental genderSat, 4 Jun 2011, 19:03:21 UTC
- UB played major role in study on drug that reduces breast cancer in high-risk womenSat, 4 Jun 2011, 17:32:33 UTC
- Breast cancer surgery patients benefit from adding radiation therapySat, 4 Jun 2011, 16:02:44 UTC
- ASCO: Emerging trends in radiation therapy for women over 70 with early stage breast cancerThu, 2 Jun 2011, 21:36:43 UTC
- Silencing a deadly conversation in breast cancerThu, 2 Jun 2011, 14:39:46 UTC
Other sources
- Breast cancer drug pushes colon cancer cells to their deathfrom Science DailyWed, 8 Jun 2011, 19:30:31 UTC
- Breast cancer drug pushes colon cancer cells to their deathfrom PhysorgWed, 8 Jun 2011, 18:30:38 UTC
- Drug prevents some breast cancersfrom Sciencenews.orgTue, 7 Jun 2011, 15:40:09 UTC
- Drug prevents some breast cancersfrom Sciencenews.orgTue, 7 Jun 2011, 14:20:10 UTC
- Breast cancer drug with fewer side effects found to cut risk of tumorsfrom LA Times - HealthMon, 6 Jun 2011, 19:30:23 UTC
- Hormone test predicts ovarian function after chemotherapy for breast cancerfrom Science DailyMon, 6 Jun 2011, 17:30:39 UTC
- Drug prevents breast cancer in some women: studyfrom CBC: HealthSun, 5 Jun 2011, 1:00:13 UTC
- Breast cancer drug with fewer side effects found to cut risk of tumorsfrom LA Times - ScienceSun, 5 Jun 2011, 0:00:28 UTC
- Drug prevents breast cancer in some women: studyfrom CBC: Technology & ScienceSun, 5 Jun 2011, 0:00:18 UTC
- Breast cancer surgery patients benefit from adding radiation therapy, study suggestsfrom Science DailySat, 4 Jun 2011, 23:30:26 UTC
- Obesity raises breast cancer survivors' risk of dying of the cancer, study findsfrom Science DailySat, 4 Jun 2011, 23:30:21 UTC
- Exemestane reduces breast cancer in high-risk women, researchers showfrom Science DailySat, 4 Jun 2011, 23:30:19 UTC
- Breast cancer drug with fewer side effects found to cut risk of tumorsfrom LA Times - HealthSat, 4 Jun 2011, 20:00:15 UTC
- Obesity raises breast cancer survivors' risk of dying of the cancerfrom PhysorgSat, 4 Jun 2011, 19:00:23 UTC
- Hormone-blocking drug reduces breast cancer riskfrom PhysorgSat, 4 Jun 2011, 18:00:18 UTC
- Estrogen blocker cuts breast cancer risk 65%: studyfrom PhysorgSat, 4 Jun 2011, 18:00:16 UTC
- Breast cancer surgery patients benefit from adding radiation therapyfrom PhysorgSat, 4 Jun 2011, 17:30:20 UTC
- UB played major role in study on drug that reduces breast cancer in high-risk womenfrom PhysorgSat, 4 Jun 2011, 17:30:19 UTC
- Study confirms long-lasting anticancer benefit of zoledronic acid for women with early-stage breast cancerfrom PhysorgFri, 3 Jun 2011, 23:30:35 UTC
- No tie found between PTEN and response to breast cancer drug herceptin, according to new studyfrom Science DailyFri, 3 Jun 2011, 23:30:28 UTC
- Emerging trends in radiation therapy for women over 70 with early stage breast cancerfrom PhysorgThu, 2 Jun 2011, 21:30:36 UTC
- Emerging trends in radiation therapy for women over 70 with early stage breast cancerfrom Science DailyThu, 2 Jun 2011, 21:30:18 UTC
- Silencing a deadly conversation in breast cancerfrom Science DailyThu, 2 Jun 2011, 14:30:29 UTC
- ‘Hedgehog’ silencer halts cancerfrom Science AlertThu, 2 Jun 2011, 14:30:23 UTC
- Silencing a deadly conversation in breast cancerfrom PhysorgThu, 2 Jun 2011, 13:30:31 UTC